DYSMEN FORTE should not be used in patients who have previously exhibited hypersensitivity to its ingredients, or another NSAID. It is contraindicated in patients with active ulceration or chronic inflammation of either the upper or lower gastrointestinal tract. DYSMEN FORTE should be avoided in patients with preexisting renal or liver disease.

DYSMEN FORTE should be administered during the first 6 months of pregnancy only if strictly required. It should be co-administered with caution along with oral anticoagulants and metoclopramide.

Reduced renal blood flow can occur in presence of impaired renal function, heart failure, liver dysfunction, in those taking diuretics, and in the elderly. In those consuming large quantities of alcohol, the therapeutic dose of DYSMEN FORTE should not be exceeded.

The most frequently reported adverse reactions associated with the use of mefenamic acid (in DYSMEN FORTE) are diarrhea, nausea with or without vomiting, and abdominal pain. Other gastrointestinal reactions less frequently reported include anorexia, pyrosis, flatulence and constipation. Gastrointestinal ulceration with and without hemorrhage can also occur with mefenamic acid (in DYSMEN FORTE). Infrequently, hypersensitivity reactions, malaise, change in appetite and weight, are possible due to mefenamic acid / paracetamol (in DYSMEN FORTE).

Mefenamic acid (inDYSMEN FORTE) can cause central nervous disturbances like drowsiness, dizziness, nervousness, headache, blurred vision, insomnia; and hematopoietic disturbances. As with other NSAIDs, renal failure, including papillary necrosis, is a possibility with mefenamic acid administration (in DYSMEN FORTE). Eye complaints, mild hepatic toxicity, perspiration, and an increased need for insulin in diabetics are possible consequences of mefenamic acid (in DYSMEN FORTE) administration.

Paracetamol can rarely cause hepatitis and hematopoietic disturbances.

ADULTS: 1 DYSMEN FORTE Tablet tid, or as prescribed.

ELDERLY CHILDREN: ½-1 DYSMEN FORTE Tablet tid, or as prescribed.